Germany
Japan
United Kingdom
China
Antibodies
View as table Download
Rabbit Polyclonal Antibody against CD19 (N-term)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This CD19 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 143-172 amino acids from the N-terminal region of human CD19. |
CD11b (ITGAM) chicken polyclonal antibody, Aff - Purified
| Applications | IF, IHC |
| Reactivities | Human, Mouse |
| Immunogen | Synthetic peptide KLH-conjugated corresponding to a sequence shared between the Mouse (NP_001076429.1) and Human gene products (NP_001139280.1). After repeated injections, immune eggs were collected, and the IgY fractions were purified from the yolks. |
BLK Rabbit Polyclonal Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | This BLK antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1-30 amino acids from the N-terminal region of human BLK. |
Inhibin beta A (INHBA) (N-term) rabbit polyclonal antibody, Aff - Purified
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
| Immunogen | This INHBA antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 85-112 amino acids from the N-terminal region of human INHBA. |
Rabbit Polyclonal Antibody against UBQLN1 (Center)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | This Ubiquilin1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 296-326 amino acids from the Central region of human Ubiquilin1. |
Rabbit Polyclonal Antibody against BRAF (Center)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This B-RAF antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 424-453 amino acids from the Central region of human B-RAF. |
Rabbit Polyclonal Antibody against STAT3 (Phospho-STAT3-Y727 ) (Phospho-Specific)
| Applications | IF, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | This STAT3 Antibody is generated from rabbits immunized with a KLH conjugated synthetic phosphopeptide corresponding to amino acid residues surrounding S727 of human STAT3. |
| Modifications | Phospho-specific |
c-Myc (MYC) chicken polyclonal antibody, Aff - Purified
| Applications | ELISA, IF, IHC, IP, WB |
| Reactivities | Human |
| Immunogen | Synthetic peptide containing the Human c-myc epitope (i.e., EQKLISEEDL) conjugated to KLH. The first injection included complete Freund's adjuvant; subsequent injections included incomplete Freund's adjuvant. Eggs were collected after the fourth injection, and antibodies were purified from the yolks using a proprietary method that yields a purity of >90%. |
Glutathione Peroxidase 1 (GPX1) (C-term) rabbit polyclonal antibody, Aff - Purified
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Mouse |
| Immunogen | Synthetic peptide - KLH conjugated - corresponding to the C-terminal region (between 164-193aa) of human Glutathione peroxidase 1 / GPX1. |
Rabbit Polyclonal Antibody against DDR1 (Center)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This DDR1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 299-330 amino acids from the Central region of human DDR1. |
Rabbit Polyclonal Antibody against DGKZ (C-term)
| Applications | IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This DGKZ antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 989-1019 amino acids from the C-terminal region of human DGKZ. |
Rabbit Polyclonal Antibody against AKT2 (N-term)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | This AKT2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 93-123 amino acids from the N-terminal region of human AKT2. |
GAD67 (GAD1) chicken polyclonal antibody, Aff - Purified
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Immunogen | Synthetic peptide KLH conjugated corresponding to a region near the C-terminus of this gene product, and was 100% conserved between the Human (Q99259), Mouse (P48318) and Rat (NP_058703) gene products. After repeated injections into the hens, immune eggs were collected, and the IgY fractions were purified from the yolks. These IgY fractions were then affinity purified using a peptide column. |
MAP2 chicken polyclonal antibody, Aff - Purified
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Immunogen | Two synthetic peptides KLH conjugated corresponding to different regions of the MAP-2 gene product, but are shared between the Human (NP_002365) and Mouse (P20357) sequences. Production: After repeated injections, immune eggs were collected, the IgY fractions were purified from the yolks. These IgY fractions were then affinity-purified using a peptide column, and the concentrations of the eluates adjusted to 200 µg/ml. Finally, equal volumes of both of these affinity purified anti-peptide antibodies were mixed, and the preparation was filter-sterilized. |
PLP1 chicken polyclonal antibody, Aff - Purified
| Applications | IF, IHC |
| Reactivities | Human, Mouse |
| Immunogen | Synthetic peptide KLH conjugated corresponding to a sequence shared between the Mouse (P60202) and Human (NP_000524) gene products. Production: After repeated injections, immune eggs were collected, the IgY fractions were purified from the yolks, and then affinity-purified using a peptide column. The concentrations of the eluates were then adjusted to 0.1 mg/ml, and the preparation was filter-sterilized. |
USD 450.00
2 Weeks
STK11 Antibody (N-term I29) Rabbit Polyclonal Antibody (Pab)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This STK11 (LKB1) antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 14-44 amino acids from the N-terminal region of human STK11 (LKB1). |
Rabbit Polyclonal Antibody against ALDH1A1 (Center)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This ALDH1A1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 302-331 amino acids from the Central region of human ALDH1A1. |
Rabbit Polyclonal Antibody against PDK4 (C-term)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | This PDK4 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 382-410 amino acids from the C-terminal region of human PDK4. |
Rabbit Polyclonal Antibody against CD9 (Center)
| Applications | FC, IF, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This CD9 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 115-145 amino acids from the Central region of human CD9. |
Rabbit Polyclonal Antibody against FRAP1 (S2481)
| Applications | IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This mTOR (FRAP1) antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 2459-2488 amino acids from human mTOR (FRAP1). |
c-Myc (MYC) chicken polyclonal antibody, FITC
| Applications | ELISA, IF, IHC, WB |
| Reactivities | Human |
| Conjugation | FITC |
| Immunogen | Synthetic peptide containing the Human c-myc epitope (i.e., EQKLISEEDL) conjugated to KLH. After repeated injections, immune eggs were collected, from which the IgY fractions were prepared. |
Choline Acetyltransferase (CHAT) chicken polyclonal antibody, Aff - Purified
| Applications | IF, IHC |
| Reactivities | Human, Mouse |
| Immunogen | Synthetic peptide KLH conjugated corresponding to a region of the Choline Acetyltransferase gene product shared between the Human (P28329) and Mouse (Q03059) sequences. After repeated injections, immune eggs were collected, the IgY fractions were purified from the yolks and then affinity-purified using a peptide column. |
Myelin Protein Zero (MPZ) chicken polyclonal antibody, Aff - Purified
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Immunogen | Two antipeptide antibodies were generated in Chickens against sequences shared between the Mouse (NP_032649) and Human (NP_000521) gene products. Production: After repeated injections, immune eggs were collected, and the IgY fractions were purified from the yolks. These IgY fractions were then affinity-purified using a peptide column, and the concentrations of the eluates adjusted to 0.2 mg/ml. Finally, equal volumes of both of these affinity purified anti-peptide antibodies were mixed, and the preparation was filter-sterilized. |
Tau (MAPT) chicken polyclonal antibody, Aff - Purified
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Immunogen | Antipeptide antibodies were generated in chickens against two sequences shared between the Mouse (P10637.3) and Human (P10636.5) gene products. Neither of these sequences contain phosphorylated serine or threonine residues, so these tau antibodies recognize both the euphosphorylated and hyperphosphorylated forms of Tau. Production: After repeated injections, immune eggs were collected, and the IgY fractions were purified from the yolks. These IgY fractions were then affinity-purified using a peptide column, and the concentrations of the eluates adjusted to 0.2 mg/ml. Finally, equal volumes of both of these affinity-purified anti-peptide antibodies were mixed, and the preparation was filter-sterilized. |
Active filters
Applications
- IF
Isotypes
- Ig
Families
- Druggable Genome
Filter by
Category
Target Symbol
- AKT2 (2)
- BNIP3L (2)
- CHAT (2)
- EDN1 (2)
- MYC (2)
- PIN1 (2)
- TP53 (2)
- ACADM (1)
- ADORA2A (1)
- AHSG (1)
- AKT1 (1)
- ALDH1A1 (1)
- ALDH2 (1)
- AMACR (1)
- BCL10 (1)
- BCL3 (1)
- BLK (1)
- BRAF (1)
- BTRC (1)
- CD14 (1)
- CD19 (1)
- CD1E (1)
- CD9 (1)
- CFH (1)
- CITED2 (1)
- CSF2 (1)
- CSNK1A1 (1)
- CTNNB1 (1)
- CYBA (1)
- DBH (1)
- DDR1 (1)
- DEK (1)
- DGKZ (1)
- DLL3 (1)
- ETS1 (1)
- FAH (1)
- FGF1 (1)
- FRAT2 (1)
- FUS (1)
- GAD1 (1)
- GBE1 (1)
- GCLC (1)
- GGH (1)
- GPX1 (1)
- GSR (1)
- GTF2H2C_2 (1)
- HNF4A (1)
- HP (1)
- HRAS (1)
- ID1 (1)
- IER3 (1)
- IL17B (1)
- INHBA (1)
- ITGAM (1)
- KAT7 (1)
- KITLG (1)
- LEP (1)
- MAP2 (1)
- MAPT (1)
- MDK (1)
- MITF (1)
- MPZ (1)
- MTOR (1)
- MUTYH (1)
- NBN (1)
- NKD2 (1)
- NR0B2 (1)
- NTN1 (1)
- PAX6 (1)
- PDE3B (1)
- PDK4 (1)
- PLCL2 (1)
- PLP1 (1)
- POSTN (1)
- PTGS2 (1)
- PTPN11 (1)
- RACGAP1 (1)
- RAD9A (1)
- SERPINA6 (1)
- SERPINI1 (1)
- SMAD4 (1)
- SP1 (1)
- SPP1 (1)
- STAT3 (1)
- STK11 (1)
- TGFB1 (1)
- TH (1)
- TIMP1 (1)
- TNFRSF1A (1)
- TNFSF15 (1)
- TOP2A (1)
- TRADD (1)
- TSSK4 (1)
- TUBB3 (1)
- UBQLN1 (1)
- WT1 (1)
Reactivities
Antibody Hosts
Clonalities
Conjugates
Modifications
Pathways
- Pathways in cancer (19)
- MAPK signaling pathway (14)
- Chronic myeloid leukemia (12)
- Colorectal cancer (11)
- Metabolic pathways (11)
- Adipocytokine signaling pathway (10)
- Endometrial cancer (10)
- Wnt signaling pathway (10)
- Acute myeloid leukemia (9)
- Jak-STAT signaling pathway (9)
- Melanoma (9)
- Pancreatic cancer (9)
- Prostate cancer (9)
- Cytokine-cytokine receptor interaction (8)
- ErbB signaling pathway (8)
- Glioma (8)
- Neurotrophin signaling pathway (8)
- Renal cell carcinoma (8)
- Small cell lung cancer (8)
- Apoptosis (7)
- Focal adhesion (7)
- Hematopoietic cell lineage (7)
- Insulin signaling pathway (7)
- Non-small cell lung cancer (7)
- TGF-beta signaling pathway (7)
- Thyroid cancer (7)
- B cell receptor signaling pathway (6)
- Bladder cancer (6)
- Cell cycle (6)
- Chemokine signaling pathway (6)
- Melanogenesis (6)
- T cell receptor signaling pathway (6)
- mTOR signaling pathway (6)
- Fc epsilon RI signaling pathway (5)
- Progesterone-mediated oocyte maturation (5)
- Regulation of actin cytoskeleton (5)
- Tight junction (5)
- Toll-like receptor signaling pathway (5)
- VEGF signaling pathway (5)
- Amyotrophic lateral sclerosis (ALS) (4)
- Huntington's disease (4)
- Leukocyte transendothelial migration (4)
- Natural killer cell mediated cytotoxicity (4)
- Basal cell carcinoma (3)
- Fc gamma R-mediated phagocytosis (3)
- Glutathione metabolism (3)
- Glycerophospholipid metabolism (3)
- Pathogenic Escherichia coli infection (3)
- RIG-I-like receptor signaling pathway (3)
- Tyrosine metabolism (3)
- beta-Alanine metabolism (3)
- Adherens junction (2)
- Alzheimer's disease (2)
- Arachidonic acid metabolism (2)
- Axon guidance (2)
- Butanoate metabolism (2)
- Cell adhesion molecules (CAMs) (2)
- Fatty acid metabolism (2)
- Gap junction (2)
- Glycerolipid metabolism (2)
- Hedgehog signaling pathway (2)
- Long-term depression (2)
- Long-term potentiation (2)
- Maturity onset diabetes of the young (2)
- Neuroactive ligand-receptor interaction (2)
- Propanoate metabolism (2)
- Valine (2)
- Vascular smooth muscle contraction (2)
- leucine and isoleucine degradation (2)
- p53 signaling pathway (2)
- Alanine (1)
- Arginine and proline metabolism (1)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (1)
- Ascorbate and aldarate metabolism (1)
- Base excision repair (1)
- Calcium signaling pathway (1)
- Complement and coagulation cascades (1)
- Dilated cardiomyopathy (1)
- Dorso-ventral axis formation (1)
- ECM-receptor interaction (1)
- Endocytosis (1)
- Epithelial cell signaling in Helicobacter pylori infection (1)
- Folate biosynthesis (1)
- Glycolysis / Gluconeogenesis (1)
- GnRH signaling pathway (1)
- Histidine metabolism (1)
- Homologous recombination (1)
- Hypertrophic cardiomyopathy (HCM) (1)
- Limonene and pinene degradation (1)
- Lysine degradation (1)
- Notch signaling pathway (1)
- Oocyte meiosis (1)
- PPAR signaling pathway (1)
- Parkinson's disease (1)
- Phosphatidylinositol signaling system (1)
- Primary bile acid biosynthesis (1)
- Primary immunodeficiency (1)
- Purine metabolism (1)
- Pyruvate metabolism (1)
- Retinol metabolism (1)
- Starch and sucrose metabolism (1)
- Taurine and hypotaurine metabolism (1)
- Tryptophan metabolism (1)
- Type I diabetes mellitus (1)
- Type II diabetes mellitus (1)
- Ubiquitin mediated proteolysis (1)
- aspartate and glutamate metabolism (1)